To view or add a comment, sign in If you think the pipeline for #ObesityMedications is exciting, consider non-pharmacotherapy options This study looking at repetitive Transcranial Magnetic Stimulation (rTMS) was conducted using comparators of semaglutide and an SGLT2 in people with #T2D and #Obesity
While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives
Uchida H, Sumimoto K, Oki T et al (2018) Isolation and characterization of 4-hydroxy-3-methylbut-2-enyl diphosphate reductase gene from Botryococcus braunii , race B
In fact, $449 per month is roughly $100 more than the unbundled price of $351 ($216 medication plus $135 membership)
Some platforms handle licensure requirements for practitioners working across multiple states